Evidence map›Paper›PMID 41479930›Full record

ArticleWorld journal of gastrointestinal endoscopy2025

Repeated hemorrhagic ulcers of the esophagus associated with acquired hemophilia A: A case report.

Makoto Saito, Kencho Miyashita, Masahiro Ieko, Emi Yokoyama, Minoru Kanaya, Koh Izumiyama, Akio Mori, Masanobu Morioka, Takeshi Kondo

Abstract readCase Reports
In one paragraph

Article in World journal of gastrointestinal endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Makoto SaitoBlood Disorders Center, Aiiku Hospital, Sapporo 064-0804, Hokkaido, Japan. ikyoku@aiiku-hp.or.jp.
Kencho MiyashitaDepartment of Gastroenterology, Aiiku Hospital, Sapporo 064-0804, Hokkaido, Japan.
Masahiro IekoDepartment of Nursing, Faculty of Health and Medical Sciences, Sapporo University of Health Sciences, Sapporo 007-0894, Hokkaido, Japan.
Emi YokoyamaBlood Disorders Center, Aiiku Hospital, Sapporo 064-0804, Hokkaido, Japan.
Minoru KanayaBlood Disorders Center, Aiiku Hospital, Sapporo 064-0804, Hokkaido, Japan.
Koh IzumiyamaBlood Disorders Center, Aiiku Hospital, Sapporo 064-0804, Hokkaido, Japan.
Akio MoriBlood Disorders Center, Aiiku Hospital, Sapporo 064-0804, Hokkaido, Japan.
Masanobu MoriokaBlood Disorders Center, Aiiku Hospital, Sapporo 064-0804, Hokkaido, Japan.
Takeshi KondoBlood Disorders Center, Aiiku Hospital, Sapporo 064-0804, Hokkaido, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAcquired hemophilia A (AHA) is a rare blood disorder that can cause life-threatening severe bleeding because of the development of autoantibodies (inhibitors) against factor VIII. AHA is common in elderly patients, and although most cases are characterized by subcutaneous or intramuscular bleeding, rare cases of gastrointestinal bleeding have been reported. Controlling gastrointestinal bleeding in patients with AHA is difficult even after multiple endoscopic hemostasis or transcatheter arterial embolization procedures, and these patients are prone to rebleeding. CASE SUMMARY: We report the case of a 76-year-old Japanese woman with AHA who presented with repeated bleeding from an esophageal ulcer as the initial symptom. A hemorrhagic ulcer was detected in the lower esophagus, and endoscopic hemostasis using radiofrequency ablation was performed seven times over a month. However, this procedure was unsuccessful, and the patient was transferred to our department. Hypertonic saline - epinephrine injection plus clipping was administered for endoscopic hemostasis, but the treatment response of the patient was poor. After the AHA diagnosis was confirmed, a single dose of a mixture of factors VIIa and X was administered as a bypass hemostatic agent, and the bleeding was successfully controlled. In addition, emicizumab, a bispecific monoclonal antibody that is a substitute for activated factor VIII, was administered, and no further rebleeding was observed.

conclusionMultidisciplinary interventions between endoscopists and hematologists are essential to manage rare gastrointestinal bleeding caused by coagulation disorders, such as AHA.

Indexed as

Acquired hemophilia ABypass hemostatic agentCase reportEmicizumabEndoscopic hemostasisEsophageal ulcerGastrointestinal bleeding

Identifiers

PMID41479930
PMCPMC12754249

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.